Charlotte M Grosskopf1, Nils B Kroemer1,2, Shakoor Pooseh1,3, Franziska Böhme1, Michael N Smolka4. 1. Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, 01187, Dresden, Germany. 2. Department of Psychiatry and Psychotherapy, University of Tübingen, 72076, Tübingen, Germany. 3. Freiburg Center for Data Analysis and Modeling (FDM), University of Freiburg, 79098, Freiburg, Germany. 4. Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, 01187, Dresden, Germany. michael.smolka@tu-dresden.de.
Abstract
INTRODUCTION: Smokers discount delayed rewards steeper than non-smokers or ex-smokers, possibly due to neuropharmacological effects of tobacco on brain circuitry, or lower abstinence rates in smokers with steep discounting. To delineate both theories from each other, we tested if temporal discounting, choice inconsistency, and related brain activity in treatment-seeking smokers (1) are higher compared to non-smokers, (2) decrease after smoking cessation, and (3) predict relapse. METHODS: At T1, 44 dependent smokers, 29 non-smokers, and 30 occasional smokers underwent fMRI while performing an intertemporal choice task. Smokers were measured before and 21 days after cessation if abstinent from nicotine. In total, 27 smokers, 28 non-smokers, and 29 occasional smokers were scanned again at T2. Discounting rate k and inconsistency var(k) were estimated with Bayesian analysis. RESULTS: First, k and var(k) in smokers in treatment were not higher than in non-smokers or occasional smokers. Second, neither k nor var(k) changed after smoking cessation. Third, k did not predict relapse, but high var(k) was associated with relapse during treatment and over 6 months. Brain activity in valuation and decision networks did not significantly differ between groups and conditions. CONCLUSION: Our data from treatment-seeking smokers do not support the pharmacological hypothesis of pronounced reversible changes in discounting behavior and brain activity, possibly due to limited power. Behavioral data rather suggest that differences between current and ex-smokers might be due to selection. The association of choice consistency and treatment outcome possibly links consistent intertemporal decisions to remaining abstinent.
INTRODUCTION: Smokers discount delayed rewards steeper than non-smokers or ex-smokers, possibly due to neuropharmacological effects of tobacco on brain circuitry, or lower abstinence rates in smokers with steep discounting. To delineate both theories from each other, we tested if temporal discounting, choice inconsistency, and related brain activity in treatment-seeking smokers (1) are higher compared to non-smokers, (2) decrease after smoking cessation, and (3) predict relapse. METHODS: At T1, 44 dependent smokers, 29 non-smokers, and 30 occasional smokers underwent fMRI while performing an intertemporal choice task. Smokers were measured before and 21 days after cessation if abstinent from nicotine. In total, 27 smokers, 28 non-smokers, and 29 occasional smokers were scanned again at T2. Discounting rate k and inconsistency var(k) were estimated with Bayesian analysis. RESULTS: First, k and var(k) in smokers in treatment were not higher than in non-smokers or occasional smokers. Second, neither k nor var(k) changed after smoking cessation. Third, k did not predict relapse, but high var(k) was associated with relapse during treatment and over 6 months. Brain activity in valuation and decision networks did not significantly differ between groups and conditions. CONCLUSION: Our data from treatment-seeking smokers do not support the pharmacological hypothesis of pronounced reversible changes in discounting behavior and brain activity, possibly due to limited power. Behavioral data rather suggest that differences between current and ex-smokers might be due to selection. The association of choice consistency and treatment outcome possibly links consistent intertemporal decisions to remaining abstinent.
Authors: Sang Soo Cho; Ji Hyun Ko; Giovanna Pellecchia; Thilo Van Eimeren; Roberto Cilia; Antonio P Strafella Journal: Brain Stimul Date: 2009-10-31 Impact factor: 8.955
Authors: Janet Audrain-McGovern; Daniel Rodriguez; Leonard H Epstein; Jocelyn Cuevas; Kelli Rodgers; E Paul Wileyto Journal: Drug Alcohol Depend Date: 2009-05-14 Impact factor: 4.492
Authors: Janet Audrain-McGovern; Daniel Rodriguez; Leonard H Epstein; Kelli Rodgers; Jocelyn Cuevas; E Paul Wileyto Journal: Addict Behav Date: 2009-07-05 Impact factor: 3.913
Authors: Aliona Tsypes; Katalin Szanto; Jeffrey A Bridge; Vanessa M Brown; John G Keilp; Alexandre Y Dombrovski Journal: J Psychopathol Clin Sci Date: 2021-11-29
Authors: Janine Thome; Mathieu Pinger; Patrick Halli; Daniel Durstewitz; Wolfgang H Sommer; Peter Kirsch; Georgia Koppe Journal: Front Psychiatry Date: 2022-06-21 Impact factor: 5.435
Authors: Stefanie Todesco; Thomas Chao; Laura Schmid; Karina A Thiessen; Christian G Schütz Journal: Front Psychiatry Date: 2022-01-28 Impact factor: 4.157